BWAY Brainsway
- 5.480
- -0.020-0.36%
Brainsway News
Trade Desk To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Baird raise
Express News | Brainsway Ltd : Oppenheimer Raises Target Price to $11 From $10
Brainsway Is Maintained at Buy by HC Wainwright & Co.
Brainsway Is Maintained at Buy by HC Wainwright & Co.
BrainsWay Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 151.68% HC Wainwright & Co. $13 → $15 Maintains Buy 03/11/2024 118.12% HC Wainwright & Co. $12
Buy Rating Affirmed for Brainsway Following Strong Financial Performance and Strategic Advancements
Express News | Brainsway Ltd : H.c. Wainwright Raises Target Price to $15 From $13
BrainsWay Announces Strong Q1 2024 Financial Growth
BrainsWay Reiterates FY24 Revenue Guidance Of $37M-$40M, Est $37.779M
This would represent growth of 16% to 26% over full-year 2023 revenue. In addition, it continues to anticipate that profitability momentum and positive cash generation will continue throughout 2024.
BrainsWay Q1 Sales $9.095M Beat $8.720M Estimate
BrainsWay (NASDAQ:BWAY) reported quarterly sales of $9.095 million which beat the analyst consensus estimate of $8.720 million by 4.30 percent. This is a 37.28 percent increase over sales of $6.625 m
6-K: Report of foreign private issuer (related to financial reporting)
Express News | Brainsway Ltd - Continue to Anticipate That Our Profitability Momentum and Positive Cash Generation Will Continue Throughout 2024
Express News | Brainsway Ltd - Reiterating Our Previously Provided Full-Year 2024 Revenue Guidance
BrainsWay Sees FY24 Rev $37M-$40M >BWAY.TA.TV
BrainsWay Sees FY24 Rev $37M-$40M >BWAY.TA.TV
BrainsWay 1Q Rev $9.1M >BWAY.TA.TV
BrainsWay 1Q Rev $9.1M >BWAY.TA.TV
BrainsWay 1Q EPS 0c >BWAY.TA.TV
BrainsWay 1Q EPS 0c >BWAY.TA.TV
BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024
BrainsWay Boosts Deep TMS Presence in Israel
Express News | Brainsway Ltd: Expects to Have Additional Deep Tms Systems Installed in Israel by End of 2024
Express News | Brainsway Ltd: Expands Deep Tms Access in Israel Following Significant Increase in Reimbursement Rates
BrainsWay Announces Published Review Results Highlighting Potential Of Deep TMS To Treat Parkinson's Disease
BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced results published in a r
Analysis
Price Target
No Data
